MDT vs. ISRG, ABT, SYK, BSX, BDX, EW, RMD, IDXX, DXCM, and STE
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Intuitive Surgical (ISRG), Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Medtronic vs.
Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.
Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Medtronic has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.
82.1% of Medtronic shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.2% of Medtronic shares are owned by insiders. Comparatively, 0.8% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Intuitive Surgical had 3 more articles in the media than Medtronic. MarketBeat recorded 60 mentions for Intuitive Surgical and 57 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.15 beat Medtronic's score of 1.11 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Medtronic presently has a consensus price target of $95.00, suggesting a potential upside of 7.68%. Intuitive Surgical has a consensus price target of $554.17, suggesting a potential downside of 6.49%. Given Medtronic's higher possible upside, analysts clearly believe Medtronic is more favorable than Intuitive Surgical.
Intuitive Surgical has a net margin of 28.51% compared to Medtronic's net margin of 13.00%. Medtronic's return on equity of 13.79% beat Intuitive Surgical's return on equity.
Medtronic received 543 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 75.61% of users gave Medtronic an outperform vote while only 69.09% of users gave Intuitive Surgical an outperform vote.
Summary
Intuitive Surgical beats Medtronic on 12 of the 19 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medtronic Competitors List
Related Companies and Tools
This page (NYSE:MDT) was last updated on 1/20/2025 by MarketBeat.com Staff
